Boenisch Sandra 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Jan 4, 2021
Insider Transaction Report
Form 4
Boenisch Sandra
PFO & Treasurer
Transactions
- Award
Stock Option (Right to Buy)
2020-12-30+50,000→ 50,000 totalExercise: $5.49Exp: 2030-12-30→ Common stock (50,000 underlying)
Footnotes (1)
- [F1]The options shall vest upon the achievement of a certain clinical trial milestone with respect to the Issuer's Phase 2/3 clinical trial program of Anavex(R)2-73 for the treatment of Rett syndrome.